About 100 reports

  • Gastrointestinal Drugs Market Competitive Landscape
  • Gastrointestinal Drugs Market Characteristics
  • Gastrointestinal Drug
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Gastrointestinal Drugs Global Market Report 2018 ##.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following: - Gastrointestinal tract disorders. - Gastrointestinal tract walls disorders. - Gastrointestinal motility disorders. -

  • Gastrointestinal Drug
  • OTC
  • World

Global Gastrointestinal Drugs Market : IGR Snapshots ##. ## Global Gastrointestinal Drugs Market key trends ##. ## Global Gastrointestinal Drugs Market by drug category ##. ## Global Gastrointestinal Drugs Market by route of administration ##. ## Global

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 07. Epidemiology of Gastrointestinal Disorders
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET BY THERAPEUTIC CLASS OF DRUG
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.
  • Zantac
  • Market trends

Offers a wide range of drugs and pharmaceuticals for the treatment of neuroscience and gastrointestinal diseases.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Other gastrointestinal disease, total (000s)
  • IBS patients with gastroenteritis, total (000s)
  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Europe
  • Italy
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES
  • Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Gastrointestinal infection
  • Proportion of Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Furiex Pharmaceuticals, Inc.
  • Patient Details
  • Drug Details

Mechanism of Action Lafutidine (Protecadin, Stogar) is an anti-ulcer drug and a gastrointestinal agent.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • Asia
  • Europe
  • World
  • Forecast
  • Other Adverse Events
  • Drug Details

Mechanism of Action Vonoprazan fumarate (Takecab) is a novel anti-secretory drug, acts as gastrointestinal Protective Agent, formulated as tablets for the oral route of administration.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Gastrointestinal Drugs
  • Six: Gastrointestinal Drugs
  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Irritable Bowel Syndrome: Executive Summary
  • 3.1 DISEASE BACKGROUND

Epidemiology and quality of life in functional gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast
  • Clinical Trial Product Information
  • Trial Results

PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2015* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2015* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO

  • Gastrointestinal Drug
  • World
  • ALTANA AG
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • Clinical Trials by G7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.
  • Digestive Remedies Sales by Region: 2012/2017/2022
  • Regional Sales of Gluten-Free Food 2012/2017/2022

Many of these new formulations are so new that their impact on digestive health market has yet to be seen, but it is already clear that the field of prevention is playing an increasingly important role in addressing gastrointestinal disorders, particularly among older consumers.

  • Gastrointestinal Drug
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • 2. H2 RECEPTOR ANTAGONISTS
  • 3. DEVELOPING H2 RECEPTOR ANTAGONISTS

GASTROINTESTINAL ULCERS TREATMENT DRUGS ARE MAINLY PROTON PUMP INHIBITORS, H## RECEPTOR BLOCKERS, MUCOSAL PROTECTIVE AGENTS, ACID AGENTS.

  • Gastrointestinal Drug
  • China
  • Demand
  • Market Size
  • Trade
  • CHAPTER IV DIGESTIVE REMEDIES DRUGS PRODUCTION AND DEMAND

THE INCIDENCE OF GASTROINTESTINAL DISEASES AROUND THE WORLD WAS ABOUT ##% OF POPULATION.

  • Gastrointestinal Drug
  • China
  • Demand
  • Market Size
  • Xian-Janssen Pharmaceutical Ltd.
  • 02. List of Abbreviations
  • 17. Market Challenges

For instance, Amitiza causes nausea, dyspnea, mechanical gastrointestinal obstruction, and diarrhea.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Valeant Pharmaceuticals International, Inc.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd Principle operation: import and export activities, international business development, purchasing and handling import of pa

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size

The largest deal during that time was the $##, ##m research, development, collaboration, and license agreement in January 2017 between Allergan and Assembly Biosciences, for the worldwide rights to Assembly’s microbiome gastrointestinal (GI) development programs.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • AstraZeneca PLC
  • Nanjing Aosaikang Medicinal Group
  • Xian-Janssen Pharmaceutical Ltd.
  • 10.2 ABBREVIATIONS
  • 2.1 CATALYST

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Gastrointestinal Drug
  • Europe
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd Principle operation: import and export activities, international business development, purchasing and handling import of pa

  • Gastrointestinal Drug
  • China
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Nanjing Aosaikang Medicinal Group

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.